CCL5 participates in early protection against Mycobacterium tuberculosis.
about
Innate immune gene polymorphisms in tuberculosisChemokine receptors and their therapeutic opportunities in diseased lung: far beyond leukocyte traffickingMicroglia are crucial regulators of neuro-immunity during central nervous system tuberculosisMycobacterium tuberculosis cell wall released fragments by the action of the human lung mucosa modulate macrophages to control infection in an IL-10-dependent mannerBacillus calmette-guerin infection in NADPH oxidase deficiency: defective mycobacterial sequestration and granuloma formation.Transcriptional profiling of disease-induced host responses in bovine tuberculosis and the identification of potential diagnostic biomarkers.Continuous and discontinuous cigarette smoke exposure differentially affects protective Th1 immunity against pulmonary tuberculosis.Granulomatous response to Coxiella burnetii, the agent of Q fever: the lessons from gene expression analysisMulti-scale modeling predicts a balance of tumor necrosis factor-α and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection.Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI StudyWhole genome response in guinea pigs infected with the high virulence strain Mycobacterium tuberculosis TT372The tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in miceT lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosisCellular and humoral mechanisms involved in the control of tuberculosisLung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice.Chemokine (C-C motif) ligand 5 -28C>G is significantly associated with an increased risk of tuberculosis: a meta-analysis.Plasma Biomarkers Can Predict Treatment Response in Tuberculosis Patients: A Prospective Observational Study.Chemokines shape the immune responses to tuberculosis.CBA/J mice generate protective immunity to soluble Ag85 but fail to respond efficiently to Ag85 during natural Mycobacterium tuberculosis infection.Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.Primary macrophages and J774 cells respond differently to infection with Mycobacterium tuberculosisMycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium?Understanding delayed T-cell priming, lung recruitment, and airway luminal T-cell responses in host defense against pulmonary tuberculosis.Chemokines in tuberculosis: the good, the bad and the ugly.Cytokines and Chemokines in Mycobacterium tuberculosis Infection.Lysosomal phospholipase A2: a novel player in host immunity to Mycobacterium tuberculosis.Killer cell lectin-like receptor G1 deficiency significantly enhances survival after Mycobacterium tuberculosis infection.CARD15 Gene Polymorphisms Are Associated with Tuberculosis Susceptibility in Chinese Holstein Cows.CCL3L1 copy number, CCR5 genotype and susceptibility to tuberculosis.Correlates of Vaccine-Induced Protection against Mycobacterium tuberculosis Revealed in Comparative Analyses of Lymphocyte Populations.Mycobacterial infection induces higher interleukin-1β and dysregulated lung inflammation in mice with defective leukocyte NADPH oxidase.Association of IL-10 and CCL5 single nucleotide polymorphisms with tuberculosis in the Sudanese population.Genotype-phenotype relationship of CCL5 in pulmonary tuberculosis infection in Sahariya tribe: A pilot study.
P2860
Q27000486-5391B188-764B-47F3-A479-9A0EE431F041Q27013008-95D34EA9-D0B5-4437-B5D3-093BD801C906Q28082627-4D0D1BF3-DF8D-44BA-8FA9-074AE22BC9C9Q33822234-F098BECE-705D-4A77-8077-EAB1A7364D20Q34134720-CAE3C56F-1F6B-48DD-B1CB-2D5EC2F1C0BDQ34168041-408C4C4D-10F7-41BB-A04E-BA5C162EB565Q34634788-065D0829-F6A3-49B9-8FB5-CCD3B45675D4Q34700042-652A169D-2650-4C9C-A6FD-DDBB091C56BFQ34837867-B6BA7FDD-1370-456F-8BA2-F0F32D863310Q35020006-194F9D72-F80D-45F2-8E65-6A99A4FB08FAQ35042642-AE8E1194-783B-4C13-B89A-75B0655FD70CQ35043659-EDDDC9B7-4F2B-4BD9-A380-4A3D9B771C2EQ35164131-741A9E4F-EACF-4CFB-8101-2DD2C005B6E7Q35996521-AD3FDF83-A11E-4C91-8981-BFFBB7BB450BQ36090847-73A6C69B-C5F7-4394-B15F-A2685562B379Q36182986-189C78F2-8C46-4161-8EE3-50A9C408A20EQ36195750-4EBF4EA6-CA5B-4581-ACEE-4EA8419F29C5Q36640097-C384B3AA-DCC4-4E81-88D3-7F583B359F26Q36811028-88D2F775-0942-4B3F-84F5-E96A8F23CCB9Q37546954-25417570-62A2-4C04-856C-F91718D967C9Q37630452-A1C22A0C-DA6A-4A2F-BFD0-288A32DB2E21Q37891772-E1B69ECB-99BF-4A89-B68D-9AD52ACABF59Q38006467-93456D94-A571-4E9D-A77F-B30608C03297Q38274693-28E735E0-E8C8-42C1-A51D-A41EB1185849Q38986062-F075394D-5B25-4C35-BA42-CC193C8774B4Q39437874-039EF1AD-B2DB-4A31-AB34-0B4A0971C514Q40227174-E46FE797-5F58-4B4A-9DD9-ED3453CC756EQ41070863-0F5212D0-0079-4385-A897-CD3744D7B744Q41883527-9097BD37-A2B3-4BAA-B38C-70F35CCE6767Q43241985-1D21EFA4-0EC2-4A23-B3C9-7021CAF99D0DQ46243855-BFF39D6B-D665-469C-9F87-E15B0A5F4F7AQ46438903-91DC24A5-0AD8-479F-BA09-86E84A3D04C3Q54234274-46969CF1-4FAA-4B5E-8D18-25EC81B0DDCB
P2860
CCL5 participates in early protection against Mycobacterium tuberculosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CCL5 participates in early protection against Mycobacterium tuberculosis.
@ast
CCL5 participates in early protection against Mycobacterium tuberculosis.
@en
type
label
CCL5 participates in early protection against Mycobacterium tuberculosis.
@ast
CCL5 participates in early protection against Mycobacterium tuberculosis.
@en
prefLabel
CCL5 participates in early protection against Mycobacterium tuberculosis.
@ast
CCL5 participates in early protection against Mycobacterium tuberculosis.
@en
P2093
P2860
P356
P1476
CCL5 participates in early protection against Mycobacterium tuberculosis.
@en
P2093
Bridget Vesosky
Erin K Rottinghaus
Gillian Beamer
Joanne Turner
Paul Stromberg
P2860
P304
P356
10.1189/JLB.1109742
P577
2010-04-06T00:00:00Z